Last 7 days
0.9%
Last 30 days
13.8%
Last 90 days
17%
Trailing 12 Months
40.2%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 442.1B | 96.0B | -4.77% | 1.21% | 23.08 | 4.6 | 5.02% | 7.14% |
LLY | 308.1B | 29.2B | -6.33% | 46.49% | 51.07 | 10.54 | 5.34% | 1.02% |
MRK | 267.0B | 59.0B | -5.13% | 34.98% | 17.49 | 4.53 | 27.84% | 112.03% |
PFE | 245.5B | 99.9B | -13.80% | -15.92% | 8.25 | 2.46 | 45.01% | 53.21% |
BMY | 154.0B | 46.7B | 0.64% | 15.96% | 23.07 | 3.3 | 2.79% | 223.53% |
MID-CAP | ||||||||
PRGO | 5.0B | 4.4B | 10.03% | -0.57% | -46.66 | 1.14 | 1.80% | 57.67% |
SUPN | 2.2B | 659.0M | 13.79% | 40.18% | 57.51 | 3.29 | 16.78% | -53.92% |
SMALL-CAP | ||||||||
TLRY | 1.9B | 613.6M | 24.42% | -38.51% | -3.79 | 3.14 | 37.73% | -7.19% |
RETA | 1.6B | 3.1M | 23.90% | 79.89% | -5.08 | 503.44 | -77.09% | -12.24% |
CGC | 1.4B | - | 33.79% | -57.23% | -0.46 | 1.95 | -4.11% | -144.36% |
ACRS | 1.2B | 23.5M | 12.85% | 73.07% | -14.2 | 49.6 | 243.57% | -1.04% |
CRON | 942.1M | 112.7M | - | -24.55% | -4.21 | 8.36 | 45.53% | 40.26% |
INVA | 885.5M | - | -2.61% | -19.99% | 2.65 | 2.34 | 10.49% | -16.07% |
OCUL | 298.8M | 49.7M | 46.97% | -25.95% | -5.03 | 6.01 | 28.95% | 32.80% |
ENDP | 94.1M | 2.6B | -43.99% | -88.43% | -0.03 | 0.04 | -13.88% | -4855.92% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
Revenue | 4.6% | 659 | 630 | 601 | 580 | 564 |
S&GA Expenses | 11.0% | 405 | 365 | 334 | 305 | 260 |
R&D Expenses | -0.1% | 78 | 78 | 77 | 90 | 87 |
Costs and Expenses | 10.9% | 641 | 578 | 527 | 494 | 441 |
EBITDA | -16.2% | 96 | 114 | 108 | 108 | - |
EBITDA Margin | -19.9% | 0.15* | 0.18* | 0.18* | 0.19* | - |
Earnings Before Taxes | -51.5% | 28 | 57 | 77 | 73 | 111 |
EBT Margin | -53.7% | 0.04* | 0.09* | 0.13* | 0.13* | - |
Interest Expenses | -79.3% | -9.50 | -5.30 | -1.64 | 3 | 2 |
Net Income | -34.5% | 38 | 57 | 73 | 53 | 82 |
Net Income Margin | -37.3% | 0.06* | 0.09* | 0.12* | 0.09* | - |
Free Cahsflow | 14.9% | 138 | 120 | 93 | 125 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
Assets | -0.1% | 1,693 | 1,695 | 1,640 | 1,689 | 1,555 |
Current Assets | 6.2% | 664 | 625 | 569 | 602 | 668 |
Cash Equivalents | -35.7% | 111 | 173 | 116 | 203 | 215 |
Inventory | -2.0% | 83 | 85 | 89 | 86 | 60 |
Net PPE | 1.5% | 17 | 17 | - | - | - |
Goodwill | 1.7% | 117 | 115 | 115 | 118 | 40 |
Liabilities | -1.5% | 840 | 854 | 811 | 873 | 745 |
Current Liabilities | -1.3% | 726 | 736 | 285 | 315 | 235 |
LT Debt, Current | 0.1% | 401 | 401 | - | - | - |
LT Debt, Non Current | NaN% | - | - | 379 | - | - |
Shareholder's Equity | 1.4% | 853 | 841 | 828 | 816 | 810 |
Retained Earnings | 0.4% | 456 | 454 | 446 | 380 | 377 |
Additional Paid-In Capital | 2.9% | 401 | 390 | 383 | 434 | 429 |
Accumulated Depreciation | 6.0% | 13 | 12 | 12 | 16 | - |
Shares Outstanding | 0% | 53 | 53 | 53 | 53 | 53 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
Cashflow From Operations | 14.9% | 138 | 120 | 95 | 127 | 110 |
Share Based Compensation | 5.8% | 17 | 16 | 18 | 18 | 17 |
Cashflow From Investing | -502.2% | -91.77 | -15.24 | -80.45 | -81.91 | -108.70 |
Cashflow From Financing | 3.3% | -150.05 | -155.18 | -154.70 | -130.42 | 9 |
100%
45%
38.1%
Y-axis is the maximum loss one would have experienced if Supernus Pharmaceuticals was unfortunately bought at previous high price.
18.4%
20.0%
-0.4%
19.6%
FIve years rolling returns for Supernus Pharmaceuticals.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-01-26 | Empowered Funds, LLC | new | - | 1,680,000 | 1,680,000 | 0.11% |
2023-01-26 | State of Tennessee, Treasury Department | added | 12.01 | 252,000 | 1,064,000 | -% |
2023-01-26 | Stephens Investment Management Group LLC | reduced | -0.06 | 3,222,000 | 57,579,000 | 1.04% |
2023-01-26 | OREGON PUBLIC EMPLOYEES RETIREMENT FUND | reduced | -0.17 | 30,899 | 627,899 | 0.01% |
2023-01-26 | STRS OHIO | unchanged | - | 1,000 | 28,000 | -% |
2023-01-26 | Eagle Bay Advisors LLC | added | 19.28 | 22,645 | 113,645 | 0.06% |
2023-01-26 | COMERICA BANK | reduced | -21.53 | -102,000 | 1,303,000 | 0.01% |
2023-01-26 | CAMPBELL NEWMAN ASSET MANAGEMENT INC | added | 3.26 | 72,925 | 894,925 | 0.09% |
2023-01-25 | Bridge City Capital, LLC | reduced | -0.71 | 100,000 | 2,248,000 | 1.15% |
2023-01-25 | Mayflower Financial Advisors, LLC | unchanged | - | 563 | 24,563 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Jan 23, 2023 | blackrock inc. | 17.8% | 9,604,073 | SC 13G/A | |
Feb 15, 2022 | armistice capital, llc | 7.8% | 4,136,000 | SC 13G/A | |
Jan 27, 2022 | blackrock inc. | 15.9% | 8,451,022 | SC 13G/A | |
Jan 26, 2022 | blackrock inc. | 15.9% | 8,451,022 | SC 13G/A | |
Feb 16, 2021 | armistice capital, llc | 5.9% | 3,120,000 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 10.06% | 5,298,078 | SC 13G/A | |
Jan 25, 2021 | blackrock inc. | 16.9% | 8,912,801 | SC 13G | |
Mar 12, 2020 | armistice capital, llc | 5.5% | 2,888,000 | SC 13G | |
Feb 12, 2020 | vanguard group inc | 10.11% | 5,305,889 | SC 13G/A | |
Feb 10, 2020 | blackrock inc. | 16.6% | 8,734,832 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Jan 23, 2023 | SC 13G/A | Major Ownership Report | |
Jan 20, 2023 | 4 | Insider Trading | |
Jan 19, 2023 | 4 | Insider Trading | |
Jan 19, 2023 | 4 | Insider Trading | |
Jan 17, 2023 | 4 | Insider Trading | |
Jan 17, 2023 | 4 | Insider Trading | |
Jan 17, 2023 | 4 | Insider Trading | |
Jan 13, 2023 | 4/A | Insider Trading | |
Jan 13, 2023 | 4/A | Insider Trading | |
Jan 12, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-01-18 | Khattar Jack A. | acquired | 77,244.8 | 9.56 | 8,080 | president, ceo |
2023-01-18 | Khattar Jack A. | sold | -199,394 | 40.3959 | -4,936 | president, ceo |
2023-01-17 | Bhatt Padmanabh P. | acquired | 44,061.4 | 9.13 | 4,826 | sr. vp of ip, cso |
2023-01-17 | Khattar Jack A. | acquired | 400,755 | 9.56 | 41,920 | president, ceo |
2023-01-17 | Bhatt Padmanabh P. | sold | -192,638 | 39.9167 | -4,826 | sr. vp of ip, cso |
2023-01-17 | Khattar Jack A. | sold | -1,018,730 | 40.0349 | -25,446 | president, ceo |
2023-01-10 | Hudson Frederick M. | acquired | 68,903.8 | 7.9 | 8,722 | - |
2023-01-06 | Bhatt Padmanabh P. | acquired | 1,588.62 | 9.13 | 174 | sr. vp of ip, cso |
2023-01-06 | Bhatt Padmanabh P. | sold | -6,942.6 | 39.9 | -174 | sr. vp of ip, cso |
2022-12-28 | NEWHALL CHARLES W III | acquired | 206,711 | 7.9 | 26,166 | - |
Condensed Consolidated Statements of Earnings - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |||
Revenues | ||||||
Total revenues | $ 177,353 | $ 148,464 | $ 499,910 | $ 420,725 | ||
Costs and expenses | ||||||
Cost of goods sold | [1] | 25,878 | 18,085 | 64,267 | 58,067 | |
Research and development | 19,554 | 19,654 | 56,778 | 69,389 | ||
Selling, general and administrative | 112,314 | 72,032 | 303,249 | 203,024 | ||
Amortization of intangible assets | 20,644 | 6,009 | 61,932 | 17,964 | ||
Contingent consideration expense (gain) | 486 | 80 | 1,894 | (7,650) | ||
Total costs and expenses | 178,876 | 115,860 | 488,120 | 340,794 | ||
Operating earnings (loss) | (1,523) | 32,604 | 11,790 | 79,931 | ||
Other income (expense) | ||||||
Interest expense | (1,724) | (5,925) | (5,476) | (17,489) | ||
Interest and other income, net | 2,803 | 2,281 | 19,289 | 8,682 | ||
Total other income (expense) | 1,079 | (3,644) | 13,813 | (8,807) | ||
Earnings (Loss) before income taxes | (444) | 28,960 | 25,603 | 71,124 | ||
Income tax (benefit) expense | (2,193) | 7,398 | (9,627) | 20,142 | ||
Net earnings | $ 1,749 | $ 21,562 | $ 35,230 | $ 50,982 | ||
Earnings per share | ||||||
Basic (in dollars per share) | $ 0.03 | $ 0.41 | $ 0.66 | $ 0.96 | ||
Diluted (in dollars per share) | $ 0.03 | $ 0.40 | $ 0.62 | $ 0.94 | ||
Weighted average shares outstanding | ||||||
Basic (in shares) | 53,789,674 | 53,187,764 | 53,517,838 | 53,053,441 | ||
Diluted (in shares) | 55,034,838 | 54,334,794 | 61,543,121 | 54,301,461 | ||
Net product sales | ||||||
Revenues | ||||||
Total revenues | $ 172,724 | $ 145,532 | $ 485,647 | $ 412,541 | ||
Royalty revenues | ||||||
Revenues | ||||||
Total revenues | $ 4,629 | $ 2,932 | $ 14,263 | $ 8,184 | ||
|
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 111,492 | $ 203,434 |
Marketable securities | 280,297 | 136,246 |
Accounts receivable, net | 164,086 | 148,932 |
Inventories, net | 83,165 | 85,959 |
Prepaid expenses and other current assets | 24,846 | 27,019 |
Total current assets | 663,886 | 601,590 |
Long-term marketable securities | 131,937 | 119,166 |
Property and equipment, net | 15,872 | 16,955 |
Intangible assets, net | 722,761 | 784,693 |
Goodwill | 117,383 | 117,516 |
Other assets | 41,290 | 49,232 |
Total assets | 1,693,129 | 1,689,152 |
Current liabilities | ||
Accounts payable and accrued liabilities | 110,302 | 117,683 |
Accrued product returns and rebates | 158,470 | 132,724 |
Contingent consideration, current portion | 47,590 | 44,840 |
Convertible notes, net | 401,438 | 0 |
Other current liabilities | 8,187 | 20,132 |
Total current liabilities | 725,987 | 315,379 |
Convertible notes, net | 0 | 379,252 |
Contingent consideration, long-term | 9,781 | 35,637 |
Operating lease liabilities, long-term | 36,028 | 41,298 |
Deferred income tax liabilities | 58,164 | 85,355 |
Other liabilities | 10,371 | 16,380 |
Total liabilities | 840,331 | 873,301 |
Stockholders’ equity | ||
Common Stock, Value, Issued | 54 | 53 |
Additional paid-in capital | 401,026 | 434,337 |
Accumulated other comprehensive earnings (loss), net of tax | (4,046) | 1,539 |
Retained earnings | 455,764 | 379,922 |
Total stockholders’ equity | 852,798 | 815,851 |
Total liabilities and stockholders’ equity | $ 1,693,129 | $ 1,689,152 |